Acumen Pharmaceuticals (ABOS) Enterprise Value
Price: $1.06
Market Cap: $64.21M
Avg Volume: 260.74K
Market Cap: $64.21M
Avg Volume: 260.74K
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Enterprise Value Summary (Quarterly)
According to Acumen Pharmaceuticals's latest quarterly financial reports:
- The enterprise value (EV) is 96.39M, which includes the market capitalization, debt, and subtracts cash and cash equivalents. EV provides a more comprehensive measure of a company's total value.
- The market capitalization is 103.22M, which is calculated by multiplying the current share price by the total number of outstanding shares.
- The stock price is $1.72, with 60.05M shares outstanding.
- The company has 35.63M in cash and cash equivalents and 28.73M in total debt.
Enterprise Value (EV) Formula:
EV = Market Cap + Total Debt - Cash and Cash Equivalents
Enterprise value is often used instead of market cap because it provides a more accurate valuation of a company by including debt and subtracting cash, giving a fuller picture of the company's total value.
Enterprise Value
$96.39M
Market Cap
$103.28M
Total Debt
$28.73M
Cash and Equivalents
$35.63M
Historical Enterprise Value
Acumen Pharmaceuticals Historical Enterprise Values
The table below shows various enterprise value metrics for each quarter, with the latest data available for 2024-12-31.
| Date | Enterprise Value | EV Change (%) | Stock Price | Number of Shares | Market Cap | Cash & Equivalents | Total Debt |
|---|---|---|---|---|---|---|---|
| December 31, 2024 | $96.39M | -33.89% | $1.72 | 60.05M | $103.28M | $35.63M | $28.73M |
| September 30, 2024 | $145.80M | 41.21% | $2.48 | 60.08M | $149.00M | $33.18M | $29.99M |
| June 30, 2024 | $103.25M | -53.26% | $2.38 | 60.08M | $142.99M | $67.95M | $28.21M |
| March 31, 2024 | $220.89M | 20.06% | $4.01 | 59.81M | $239.85M | $46.93M | $27.97M |
| December 31, 2023 | $183.98M | 41.37% | $3.84 | 57.91M | $222.38M | $66.89M | $28.49M |
| September 30, 2023 | $130.14M | 8.35% | $4.15 | 54.23M | $225.05M | $94.92M | $2.00K |
| June 30, 2023 | $120.11M | 35.52% | $4.81 | 41.03M | $197.33M | $77.25M | $29.00K |
| March 31, 2023 | $88.63M | -2.24% | $4.06 | 41.03M | $166.56M | $78.00M | $67.00K |
| December 31, 2022 | $90.66M | -63.57% | $5.4 | 40.86M | $220.66M | $130.10M | $105.00K |
| September 30, 2022 | $248.84M | 213.25% | $10.03 | 40.50M | $406.24M | $157.54M | $133.00K |
| June 30, 2022 | $79.44M | 59.87% | $4.7 | 40.50M | $190.34M | $111.07M | $167.00K |
| March 31, 2022 | $49.69M | -63.60% | $3.91 | 40.47M | $158.25M | $108.76M | $201.00K |
| December 31, 2021 | $136.52M | -68.46% | $6.76 | 38.27M | $258.68M | $122.16M | $- |
| September 30, 2021 | $432.84M | -38.87% | $14.86 | 38.27M | $568.64M | $135.80M | $- |
| June 30, 2021 | $708.09M | 0.87% | $20.1 | 38.65M | $776.90M | $68.81M | $- |
| March 31, 2021 | $701.99M | 31.92% | $20.1 | 36.99M | $743.40M | $41.41M | $- |
| December 31, 2020 | $532.12M | -7.60% | $20.1 | 28.65M | $575.90M | $43.78M | $- |
| September 30, 2020 | $575.90M | 0.00% | $20.1 | 28.65M | $575.90M | $- | $- |
| June 30, 2020 | $575.90M | -1.12% | $20.1 | 28.65M | $575.90M | $- | $- |
| March 31, 2020 | $582.45M | - | $20.1 | 28.65M | $575.90M | $-6.55M | $- |
Related Metrics
Explore detailed financial metrics and analysis for ABOS.